Stocktoria
Merck & Co., Inc. MRK
Merck & Co., Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.0B | $64.2B | $60.1B | $59.3B | $48.7B | $41.5B | $39.1B | $42.3B | $40.1B | $39.8B |
| R&D expense | $15.8B | $17.9B | $30.5B | $13.5B | $12.2B | $13.4B | $9.7B | $9.8B | $10.3B | $10.3B |
| SG&A expense | $10.7B | $10.8B | $10.5B | $10.0B | $9.6B | $9.0B | $9.5B | $10.1B | $10.1B | $10.0B |
| Interest expense | — | — | $1.1B | $962.0M | $806.0M | $831.0M | $893.0M | $772.0M | $754.0M | $693.0M |
| Income tax | $2.8B | $2.8B | $1.5B | $1.9B | $1.5B | $1.3B | $1.6B | $2.5B | $4.1B | $718.0M |
| Net income | $18.3B | $17.1B | $365.0M | $14.5B | $13.0B | $7.1B | $9.8B | $6.2B | $2.4B | $3.9B |
| EPS (diluted) | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 | $2.78 | $3.81 | $2.32 | $0.87 | $1.41 |
| Operating cash flow | $16.5B | $21.5B | $13.0B | $19.1B | $13.1B | $10.3B | $13.4B | $10.9B | $6.5B | $10.4B |
| Free cash flow | $12.4B | $18.1B | $9.1B | $14.7B | $8.7B | — | — | — | — | — |
| Cash & equivalents | $14.6B | $13.2B | $6.8B | $12.7B | $8.1B | $8.1B | $9.7B | $8.0B | $6.1B | $6.5B |
| Inventory | $6.7B | $6.1B | $6.4B | $5.9B | $6.0B | $5.6B | $6.0B | $5.4B | $5.1B | $4.9B |
| Total assets | $136.9B | $117.1B | $106.7B | $109.2B | $105.7B | $91.6B | $84.4B | $82.6B | $87.9B | $95.4B |
| Shareholders' equity | $52.7B | $46.4B | $37.6B | $46.1B | $38.3B | $25.4B | $26.0B | $26.9B | $34.6B | $40.3B |
Growth · year-over-year · Revenue CAGR 5.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.3% | +6.7% | +1.4% | +21.7% | +17.3% | +6.1% | -7.5% | +5.4% | +0.8% | — |
| Net income growth | +6.6% | +4589.6% | -97.5% | +11.3% | +84.6% | -28.2% | +58.2% | +159.8% | -38.9% | -11.8% |
| EPS growth | +8.0% | +4714.3% | -97.5% | +11.1% | +84.9% | -27.0% | +64.2% | +166.7% | -38.3% | -9.6% |
| Free cash flow growth | -31.7% | +97.9% | -37.8% | +69.6% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.